Nishan M Desilva - Net Worth and Insider Trading
Nishan M Desilva Net Worth
The estimated net worth of Nishan M Desilva is at least $2 Million dollars as of 2024-04-20. Nishan M Desilva is the VP, Finance & Strategy and CFO of Ligand Pharmaceuticals Inc and owns about 22,282 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $2 Million. Nishan M Desilva is also the Director of Cartesian Therapeutics Inc and owns about 233 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $4,159. Details can be seen in Nishan M Desilva's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nishan M Desilva has not made any transactions after 2021-12-02 and currently still holds the listed stock(s).
Transaction Summary of Nishan M Desilva
Nishan M Desilva Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nishan M Desilva owns 2 companies in total, including Ligand Pharmaceuticals Inc (LGND) , and Cartesian Therapeutics Inc (RNAC) .
Click here to see the complete history of Nishan M Desilva’s form 4 insider trades.
Insider Ownership Summary of Nishan M Desilva
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2015-05-14 | VP & Corporate Development |
| RNAC | Cartesian Therapeutics Inc | 2021-12-02 | director |
Nishan M Desilva Latest Holdings Summary
Nishan M Desilva currently owns a total of 2 stocks. Among these stocks, Nishan M Desilva owns 22,282 shares of Ligand Pharmaceuticals Inc (LGND) as of May 14, 2015, with a value of $2 Million and a weighting of 99.74%. Nishan M Desilva also owns 233 shares of Cartesian Therapeutics Inc (RNAC) as of December 2, 2021, with a value of $4,159 and a weighting of 0.26%.
Latest Holdings of Nishan M Desilva
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2015-05-14 | 22,282 | 72.48 | 1,614,999 |
| RNAC | Cartesian Therapeutics Inc | 2021-12-02 | 233 | 17.85 | 4,159 |
Holding Weightings of Nishan M Desilva
Nishan M Desilva Form 4 Trading Tracker
According to the SEC Form 4 filings, Nishan M Desilva has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 68,363 shares on May 14, 2015, which brought Nishan M Desilva around $6 Million.
According to the SEC Form 4 filings, Nishan M Desilva has made a total of 1 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cartesian Therapeutics Inc is the acquisition of 233 shares on December 2, 2021, which cost Nishan M Desilva around $20,720.
Insider Trading History of Nishan M Desilva
- 1
Nishan M Desilva Trading Performance
GuruFocus tracks the stock performance after each of Nishan M Desilva's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nishan M Desilva is -13.35%. GuruFocus also compares Nishan M Desilva's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nishan M Desilva within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nishan M Desilva's insider trading performs compared to the benchmark.
Performance of Nishan M Desilva
Average Return
4.47%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.97 | -13.35 | -14.19 | 4.47 | 10.1 | 46.47 |
| Relative Return to S&P 500(%) | 14.25 | -13.93 | -17.13 | -1.05 | 2.79 | 38.25 |
Nishan M Desilva Ownership Network
Ownership Network List of Nishan M Desilva
Ownership Network Relation of Nishan M Desilva
Nishan M Desilva Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Nishan M Desilva is the VP & Corporate Development of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include Chief Financial Officer Octavio Espinoza , CHIEF LEGAL OFFICER & Andrew Reardon , and CEO & President John L Higgins .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Nishan M Desilva made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 20,000 shares made by John L Higgins , a net sale of 10,852 shares made by John W Kozarich , and a net sale of 8,301 shares made by Stephen L Sabba .
In summary, during the past 3 months, insiders sold 2,033 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 2,033 shares. During the past 18 months, 41,289 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 37,289 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Nishan M Desilva Mailing Address
Above is the net worth, insider trading, and ownership report for Nishan M Desilva. You might contact Nishan M Desilva via mailing address: 11119 North Torrey Pines Rd Ste 200, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
